Anna Wolska, PhD, MS
Dr. Anna Wolska is currently a staff scientist at the National Heart, Lung, and Blood Institute (NHLBI) in the Epidemiology and Community Health Branch (ECHB). She received her MS degree in 2009 at University of Gdansk and PhD in 2014 at Medical University of Gdansk (MUG) in Poland. Dr. Wolska also completed postgraduate studies in laboratory medicine at MUG and became a certified Clinical Chemist. Before joining ECHB, she was for over 6 years a research fellow in the laboratory of Dr. Alan Remaley at the NHLBI. Dr. Wolska has over 12 years of experience in biomedical sciences and broad training in basic science, translational medicine and molecular epidemiology related to hypertriglyceridemia and cardiovascular diseases. She has published over 30 articles, many in high-impact factor journals, which have been widely commented in press-media. Recently, she received 2020 Orloff Science Award from NHLBI and 2021 Young Investigator Award from the European Atherosclerosis Society.